granted
on 03 May 2024
Last Applicant/ Owned by
840 Memorial Drive
Cambridge
MA
02139
Serial Number
97111780 filed on 05th Nov 2021
Registration Number
N/A
Correspondent Address
Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immRead More
Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicines
11th 000101
11th 000101
Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations
11th 000101
11th 000101
No 97111780
No Service Mark
No 53676-TM1003
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 04th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd May 2024 | SOU EXTENSION 3 FILED |
| 03rd May 2024 | SOU TEAS EXTENSION RECEIVED |
| 03rd May 2024 | SOU EXTENSION 3 GRANTED |
| 19th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Oct 2023 | SOU EXTENSION 2 GRANTED |
| 17th Oct 2023 | SOU EXTENSION 2 FILED |
| 17th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
| 17th May 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th May 2023 | SOU EXTENSION 1 FILED |
